Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics | $14.31 | -$11.29 | -44.10% | 2.1M | $2.7B | $5.90$28.25 |
| GNTA | Genenta Science S.p.A. | $3.47 | -$2.73 | -44.03% | 1.3M | $118.7M | $2.56$10.00 |
| SLGB | Smart Logistics Global | $2.93 | -$2.17 | -42.55% | 7.5M | $209.1M | $2.42$6.08 |
| IRBT | iRobot | $3.81 | -$1.77 | -31.77% | 336.1K | $175.0M | $1.76$13.06 |
| OGN | Organon & Co. | $7.13 | -$2.03 | -22.17% | 26M | $2.4B | $6.80$19.05 |
| FLWS | 1-800-Flowers.com | $3.83 | -$1.05 | -21.46% | 3M | $309.8M | $3.70$9.24 |
| NEUP | Neuphoria Therapeutics | $4.94 | -$1.30 | -20.83% | 1.9M | $11.7M | $2.12$21.40 |
| PRE | Prenetics Global | $13.30 | -$3.47 | -20.67% | 614.9K | $218.4M | $3.09$17.99 |
| NBTX | Nanobiotix | $15.37 | -$3.84 | -19.97% | 144.6K | $920.1M | $2.76$30.35 |
| QBTZ | Tidal Trust II - Defiance Daily Target 2x Short Qbts ETF | $11.71 | -$2.70 | -18.74% | 8.3M | - | $8.77$23.47 |
Related Articles
Featured Article
Is the White House About to Invest in These Lithium and Rare Earth Miners?
Matthew Benjamin|Oct 12, 2025
The U.S. government may be eyeing investments in mining companies, sending their shares higher.
1 Stock Up by 63% This Year That Could Double, According to Wall Street
Prosper Junior Bakiny|Oct 7, 2025
Some math suggests that even Wall Street is lowballing the stock's potential.
2 Incredible Growth Stocks to Buy With $1,000
George Budwell|Sep 27, 2025
One stock has soared 173% this year on momentum from critical minerals, while the other is down 23% despite growing revenue in the mid-teens annually.
Can This Beaten-Down Stock Bounce Back?
Prosper Junior Bakiny|Aug 12, 2025
This small-cap biotech is seeking to develop breakthrough therapies, but so far it's found little success.
2 Beaten-Down Stocks to Avoid
Prosper Junior Bakiny|Jun 27, 2025
Down 33% in 1 Month, Should You Buy the Dip With Intellia Therapeutics Stock?
Alex Carchidi|Nov 22, 2024
Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?
Alex Carchidi|Nov 6, 2024
There's nothing bearish at all about what it reported recently.
This Beaten-Down Stock Could Soar by 354%, According to Wall Street
Prosper Junior Bakiny|Nov 4, 2024
Maybe the Street is a bit too optimistic on this one.
This Beaten-Down Growth Stock Could Skyrocket 234%, According to Wall Street
George Budwell|Oct 17, 2024
Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach for volatility.
